|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| C07D 413/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2579877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11725494.6 |
| Date of filing the European patent application | 2011-06-09 | |
| (97) | Date of publication of the European application | 2013-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-13 |
| (46) | Date of publication of the claims translation | 2014-11-25 |
| (86) | Number | PCT/GB2011/051074 |
| Date | 2011-06-09 |
| (87) | Number | WO 2011/154737 |
| Date | 2011-12-15 |
| (30) | Number | Date | Country code |
| 353713 P | 2010-06-11 | US |
| (72) |
FOOTE, Kevin, Michael, GB
NISSINK, Johannes, Wilhelmus, Maria, GB
TURNER, Paul, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Morfolino pirimidinai ir jų panaudojimas terapijoje |
| MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 15 | 289.00 EUR |
| 2026-06-09 |